Abstract
Vestibular disorders such as vestibular migraine (VM), benign paroxysmal positional vertigo (BPPV), Ménière's disease (MD), persistent postural-perceptual dizziness (PPPD), and vestibular neuritis (VN) are not uncommon among women of reproductive age and may occur or worsen during pregnancy. However, the management of these disorders during gestation is complicated by physiological changes, the limited safety data on many medications, and ethical constraints in clinical research involving pregnant individuals. This review focuses on the therapeutic strategies employed in managing vestibular disorders during pregnancy, highlighting pharmacological and non-pharmacological interventions, evidence-based approaches, current limitations, and areas requiring further research. Emphasis is placed on safety profiles, individualized care, and interdisciplinary collaboration to optimize maternal health while minimizing fetal risk.